Protara Therapeutics, Inc. (TARA) has a consensus analyst rating of Buy, based on 5 analysts covering the stock. Of those, 5 recommend buying, 0 recommend holding, and 0 recommend selling.
The analyst consensus price target for TARA is $12.00, representing a +133.9% upside from the current price of $5.13. Price targets range from a low of $12.00 to a high of $12.00.
